General Announcement::ASX:NASDAQ:TLX: Webinar - A Next-Gen Portfolio Approach to PSMA Therapy

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Apr-2026 07:12:01
Status
New
Announcement Sub Title
ASX:NASDAQ:TLX: Webinar - A Next-Gen Portfolio Approach to PSMA Therapy
Announcement Reference
SG260428OTHRK4G8
Submitted By (Co./ Ind. Name)
Nick Golding
Designation
Assistant Company Secretary
Effective Date and Time of the event
28/04/2026 07:15:00
Description (Please provide a detailed description of the event in the box below)
ASX:NASDAQ:TLX: Webinar - A Next-Gen Portfolio Approach to PSMA Therapy

Attachments

20260328 TLX597-Tx webinar vFINAL.pdf
Total size =213K